Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation
Crossref DOI link: https://doi.org/10.1007/s12282-017-0821-9
Published Online: 2017-11-27
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Zong-Lin
Jiang, Qing-Cheng
Wang, Su-Rong
License valid from 2017-11-27